XCUR
NSCExicure Inc.
Healthcare•Biotechnology
Watchlist:
Last updated: Monday 7th July 2025
6.78
+0.82 (13.76%)
Prev Close:5.96
Open:5.915
Bid:6.5
Ask:6.8
52 Week Range
1.4436.00
Volume:95,711
Mkt Cap:39 M
24
MarketXLS Rank ®
Weak Hold
Price Target
$7.80
+15.0%
Financials
Financial Statements
XCUR - Balance Sheet (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Invalid date | |
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1 M | 2 M | 361000.0 | 3 M | 2 M | 2 M | 500000.0 | 1 M | |
| Accounts Receivable | 11000.0 | 16000.0 | |||||||
| Accrued Expenses | 3 M | 3 M | 2 M | 10 M | 5 M | 4 M | 2 M | 2 M | |
| Accrued Interest Receivable | 236000.0 | ||||||||
| Accumulated Depreciation & Depletion | -253000.0 | -225000.0 | -4 M | -3 M | -2 M | -1 M | -1 M | -849000.0 | |
| Additional Paid In Capital | 206 M | 193 M | 188 M | 181 M | 167 M | 162 M | 76 M | 54 M | |
| Cash And Equivalents | 13 M | 816000.0 | 9 M | 35 M | 33 M | 48 M | 26 M | 26 M | |
| Cash Cash Equivalents And Short Term Investments | 13 M | 816000.0 | 9 M | 39 M | 82 M | 111 M | 26 M | 26 M | |
| Cash Equivalents | 13 M | 816000.0 | 48 M | 26 M | 26 M | ||||
| Common Par | 1000.0 | 1000.0 | 11000.0 | 9000.0 | 9000.0 | 4000.0 | 4000.0 | ||
| Common Stock Equity | 7 M | 3 M | 15 M | 11 M | 62 M | 81 M | 21 M | 20 M | |
| Common Stock | 1000.0 | 3 M | 15 M | 11 M | 9000.0 | 9000.0 | 4000.0 | 4000.0 | |
| Current Accrued Expenses | 2 M | 879000.0 | 1 M | 6 M | 4 M | 2 M | 2 M | 1 M | |
| Current Capital Lease Obligation | 722000.0 | 626000.0 | 539000.0 | 459000.0 | 223000.0 | 292000.0 | 347000.0 | 341000.0 | |
| Current Deferred Revenue | 17 M | 8 M | 22 M | 1 M | |||||
| Current Deferred Taxes Assets | 132000.0 | 2 M | 3 M | 3 M | 3 M | 158000.0 | 60000.0 | 295000.0 | |
| Current Deferred Taxes Liabilities | -132000.0 | -2 M | -3 M | -3 M | -3 M | ||||
| Current Provisions | 523000.0 | ||||||||
| Deferred Revenues | 17 M | 8 M | 22 M | 1 M | |||||
| Float Term Debt | 5 M | 6 M | 7 M | 7 M | 25 M | 5 M | 5 M | 5 M | |
| Gross Fixed Assets (plant Property & Equipment) | 279000.0 | 7 M | 13 M | 15 M | 14 M | 4 M | 2 M | 2 M | |
| Invested Capital | 12 M | 9 M | 22 M | 29 M | 103 M | 81 M | 26 M | 25 M | |
| Long Term Capital Lease Obligation | 5 M | 6 M | 7 M | 7 M | 8 M | 59000.0 | |||
| Long Term Debt And Capital Lease Obligation | 5 M | 6 M | 7 M | 7 M | 25 M | 59000.0 | 5 M | 5 M | |
| Long Term Provisions | 414000.0 | 797000.0 | 523000.0 | ||||||
| Net Fixed Assets (net PP&E) | 26000.0 | 7 M | 10 M | 12 M | 13 M | 2 M | 1 M | 1 M | |
| Non Current Accrued Expenses | 39000.0 | 48000.0 | |||||||
| Non Current Deferred Liabilities | 12 M | 3 M | |||||||
| Non Current Deferred Revenue | 12 M | 3 M | 39000.0 | ||||||
| Non Current Deferred Taxes Assets | -7 M | -4 M | -44 M | -52 M | -30 M | 24 M | 16 M | 10 M | |
| Other Current Assets | 24000.0 | 274000.0 | |||||||
| Other Equity Adjustments | -27000.0 | ||||||||
| Other Fixed Assets | 26000.0 | 7 M | 10 M | 12 M | 13 M | ||||
| Other Non-current Assets | 1 M | 3 M | 3 M | 9 M | 1 M | 32000.0 | 32000.0 | 32000.0 | |
| Other Non-current Liabilities | 656000.0 | 656000.0 | 59000.0 | 39000.0 | 278000.0 | ||||
| Other Receivable | 521000.0 | 15000.0 | 17 M | 19000.0 | 3000.0 | 30000.0 | |||
| Other Current Liabilities | 71000.0 | 48000.0 | 1 M | 1 M | |||||
| Other Payable | 1 M | ||||||||
| Payables | 1 M | 2 M | 361000.0 | 3 M | 2 M | 2 M | 500000.0 | 1 M | |
| Preferred Securities Of Subsidiary Trust | 10 M | 10 M | 10 M | ||||||
| Preferred Stock | 10 M | 10 M | 10 M | ||||||
| Prepaid Expenses | 644000.0 | 1 M | 1 M | 5 M | 4 M | 2 M | 1 M | 2 M | |
| Restricted Cash | 13 M | 2 M | 10 M | 9 M | 1 M | ||||
| Retained Earnings | -199 M | -190 M | -173 M | -170 M | -106 M | -81 M | -55 M | -34 M | |
| Short Term Debt | 7 M | 5 M | |||||||
| Total Assets | 15 M | 12 M | 23 M | 65 M | 100 M | 115 M | 29 M | 29 M | |
| Total Current Assets | 14 M | 2 M | 10 M | 44 M | 86 M | 113 M | 28 M | 28 M | |
| Total Current Liabilities | 3 M | 3 M | 2 M | 34 M | 14 M | 31 M | 2 M | 3 M | |
| Total Equity | 7 M | 3 M | 15 M | 11 M | 62 M | 81 M | 21 M | 20 M | |
| Total Liabilities | 8 M | 9 M | 8 M | 54 M | 39 M | 35 M | 8 M | 9 M | |
| Total Non-current Assets | 1 M | 10 M | 13 M | 21 M | 14 M | 2 M | 1 M | 1 M | |
| Total Non-current Liabilities | 5 M | 6 M | 7 M | 20 M | 25 M | 3 M | 6 M | 6 M | |
| Total Equity Gross Minority | 7 M | 3 M | 15 M | 11 M | 62 M | 81 M | 21 M | 20 M | |
| Total Equity Gross Minority Interest | 7 M | 3 M | 15 M | 11 M | 62 M | 81 M | 21 M | 20 M | |
| Total Liabilities And Total Equity Gross Minority Interest | 15 M | 12 M | 23 M | 65 M | 100 M | 115 M | 29 M | 29 M | |
| Total Non Current Liabilities Net Minority Interes | 5 M | 6 M | 7 M | 20 M | 25 M | 3 M | 6 M | 6 M | |
| Unearned Premiums | -627000.0 | -911000.0 | |||||||
| Working Capital | 11 M | -486000.0 | 8 M | 10 M | 73 M | 82 M | 26 M | 24 M | |
| Debtc | 7 M | 5 M |
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.
I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...
MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.